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Abstract Mig1p is a zinc finger protein required for repression
of glucose-regulated genes in budding yeast. On removal of
medium glucose, gene repression is relieved via a mechanism that
requires the SNF1 protein kinase complex. We show that Mig1p
expressed as a glutathione-S-transferase fusion in bacteria is
readily phosphorylated by the SNF1 kinase in vitro. Four
phosphorylation sites were identified, i.e. Ser-222, Ser-278, Ser-
311 and Ser-381. The latter three are exact matches to the
recognition motif we previously defined for SNF1 and lie within
regions shown to be required for SNF1-dependent derepression
and nuclear-to-cytoplasmic translocation.
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1. Introduction
Glucose is the preferred carbon source for the budding
yeast Saccharomyces cerevisiae. Glucose repression (catabolite
repression) is the phenomenon whereby a battery of genes,
e.g. those required for catabolism of alternative carbon sour-
ces, is switched o¡ in the presence of high glucose. The SNF1
(CAT1, CCR1) and SNF4 (CAT3) genes are essential for dere-
pression of these genes when glucose is removed [1,2]. The
SNF1 gene product (Snf1p) has a protein kinase domain at
the N-terminus [3], while Snf4p is a regulatory subunit that
forms a complex with Snf1p in vitro and in vivo [4^7]. The
SIP1, SIP2 and GAL83 gene products represent alternate
third subunits of the complex, which interact with Snf1p
and Snf4p via conserved binding domains [8,9].
The mammalian homologue of the SNF1 complex is the
AMP-activated protein kinase (AMPK) [10], a heterotrimer
of K, L and Q subunits which are homologues of Snf1p,
Sip1p/Sip2p/Gal83p and Snf4p, respectively [11^14]. AMPK
is activated by elevation of AMP and depletion of ATP, via a
complex multistep mechanism involving phosphorylation by
an upstream kinase [15^19]. We have recently demonstrated
that the kinase activity of the SNF1 complex is activated on
removal of glucose from the medium [7,20], via a mechanism
which also involves increased phosphorylation by an upstream
kinase. The activating signal in yeast remains unclear,
although activation is associated with large increases in
AMP and decreases in ATP in vivo [7].
How the activated SNF1 complex derepresses glucose-re-
pressed genes has also been unclear, although a number of
genes which act downstream of SNF1 have been de¢ned by
genetic studies. The MIG1 gene is of particular interest, in
that mutations lead to partially constitutive expression of glu-
cose-repressed genes, but not of other genes. Mig1p is a C2H2
zinc ¢nger DNA-binding protein that binds to the promoter
of several glucose-repressible genes [21^24]. Mig1p regulates
repression of these genes by recruiting the co-repressors Ssn6p
and Tup1p. The phosphorylation of Mig1p is increased under
derepressing conditions [25] and is associated with its trans-
location from the nucleus to the cytoplasm [26]. Since both
Snf1p and Snf4p have been reported to be partly nuclear [3,4],
a simple hypothesis would be that on removal of glucose,
Mig1p is directly phosphorylated by SNF1 within the nucleus,
resulting in translocation to the cytoplasm and loss of its
ability to repress transcription. In this paper, we show that
the SNF1 complex phosphorylates Mig1p in vitro and identify
four phosphorylation sites located at, or near, regions that
have been shown to be required for SNF1-dependent relief
from repression [27] or nuclear to cytoplasmic translocation
[26].
2. Materials and methods
2.1. Materials
Anti-FLAG M2 resin was from Sigma. The SNF1 complex was
puri¢ed from yeast as described previously [7].
2.2. Expression and puri¢cation of Mig1p in bacteria and yeast
Mig1 was ampli¢ed from S. cerevisiae cDNA (Clontech) using the
polymerase chain reaction (PCR) and cloned into pGEX4T-3 (Amer-
sham Pharmacia Biotech) for expression of glutathione-S-transferase
(GST)-Mig1p in bacteria or pYX212 (R and D Systems) for expres-
sion of Mig1p in yeast. For Mig1p expressed in yeast, a sequence
encoding the FLAG epitope tag (DYKDDDDK) was incorporated
into the cDNA immediately following the initiating methionine. The
serine residues identi¢ed as sites phosphorylated by SNF1 in vitro
were altered to aspartic acid residues (222, 278, 381) or glutamic
acid (311) by site-directed mutagenesis using the splicing by overlap
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extension PCR technique. GST-Mig1p was puri¢ed from 500 ml cul-
tures by chromatography on glutathione-Sepharose 4B (Amersham
Pharmacia Biotech), according to the manufacturer’s instructions.
FLAG epitope-tagged Mig1p was expressed in vmig1 yeast (strain
MYC3640) and immunoprecipitated from cell lysates (1 mg total pro-
tein) with 40 Wl of a 50% slurry (v/v) of anti-FLAG resin (Sigma).
Immune complexes were washed extensively with 25 mM HEPES, pH
7.4, 50 mM NaCl, 10% glycerol, 1% Triton X-100 and used for phos-
phorylation by SNF1.
2.3. Phosphorylation of Mig1p by the SNF1 complex
GST-Mig1p (1.3 mg/ml) was incubated for 30 min at 30‡C with
SNF1 (4.3 U/ml), MgCl2 (4.7 mM) and [Q-32P]ATP (357 000 dpm/
nmol, 187 WM) in Na-HEPES (50 mM, pH 7.0), dithiothreitol (1
mM), Brij-35 (0.02% (w/v)). Mig1p expressed in yeast was phospho-
rylated in the immune complex with anti-FLAG resin using the same
conditions. In some cases, the reaction was stopped by adding 5Uso-
dium dodecyl sulfate (SDS) gel sample bu¡er followed by electropho-
resis in 10% polyacrylamide gels [28]. The gel was stained with Coo-
massie blue, dried and subjected to autoradiography. In other cases,
the reaction was stopped by adding ice-cold trichloroacetic acid
(TCA) to 25% (w/v), the pellet was recovered by centrifugation
(14 000Ug, 2 min) and washed three times by addition of 1 ml of
25% TCA, vortexing and recentrifugation. The radioactivity in the
pellet was determined by Cerenkov counting.
2.4. Analysis of phosphorylation sites on GST-Mig1p
TCA pellets containing 32P-labelled GST-Mig1p were washed once
with water and resuspended in Tris-HCl (50 mM, pH 8.0), dithiothrei-
tol (1 mM), Brij-35 (0.02% (w/v). Trypsin was added (1:10 by weight)
and the suspension incubated for 2 h at 37‡C. The suspension was
centrifuged (14 000Ug, 2 min) and the supernatant (83% of total
radioactivity) was applied to a Sep-Pak cartridge (Waters), eluted
with 50% (v/v) acetonitrile containing 0.1% (v/v) tri£uoroacetic acid
(TFA) (86% recovery) and taken to near dryness in a Speedvac con-
centrator. The sample was applied to a Vydac Protein and Peptide
C18 column (25U0.46 cm) equilibrated with 0.1% (v/v) TFA and
eluted with a gradient from 0.1% TFA in water to 0.1% TFA in
acetonitrile as shown in Fig. 2A. Phosphopeptides were further puri-
¢ed by chromatography on Fe3 bound to iminodiacetate-agarose gel
[29] and by microbore HPLC on a Vydac Protein and Peptide C18
column (15U0.21 cm) in 0.09% TFA, eluting at 0.2 ml/min with a
gradient from 0 to 70% acetonitrile over 140 min. Phosphopeptides
were sequenced on an ABI 476A sequencer using a conventional
pulsed liquid protocol to determine the PTH-amino acid released
and by solid phase sequencing on an ABI 470A sequencer using pep-
tides covalently attached to Sequelon membranes to determine the
release of radioactivity.
3. Results
3.1. Expression of Mig1p and phosphorylation by SNF1
Mig1p was expressed as a fusion protein with GST and
puri¢ed by a⁄nity chromatography on glutathione-Sephar-
ose. Despite a number of e¡orts, we were unable to prevent
extensive degradation of the GST-Mig1p protein and the pro-
portion of intact full length GST-Mig1p (predicted molecular
mass 82 kDa) was below 1%, as judged by densitometric scan-
ning of Coomassie-stained gels (data not shown). However, as
shown in Fig. 1, SNF1, puri¢ed to near homogeneity as de-
scribed previously [7,30], phosphorylated the 82 kDa polypep-
tide corresponding to full length GST-Mig1p and most of its
major breakdown products. GST was not phosphorylated by
SNF1 and there was no signi¢cant phosphorylation in con-
trols containing SNF1 or GST-Mig1p alone. Due to the large
spread of molecular masses of the phosphorylated polypep-
tide, we could not get an accurate estimate of the stoichiom-
etry of phosphorylation. However, assuming an ‘average’ mo-
lecular mass of 40 kDa, the maximum labelling was around
0.63 mol phosphate per mole protein. The stoichiometry of
phosphorylation of the full length GST-Mig1p was certainly
higher than this, because this polypeptide was more strongly
labelled, although less abundant than the major breakdown
products.
3.2. Identi¢cation of phosphorylation sites within Mig1p
Pilot experiments (not shown) showed that a very similar
tryptic peptide map was obtained when we digested the total
phosphorylated protein, rather than just the full length GST-
Mig1p polypeptide excised from a gel. In further experiments,
we therefore digested the total protein without prior gel sep-
aration. Fig. 2A shows a HPLC analysis of tryptic peptides,
revealing the presence of four major peaks labelled 1^4 in
order of elution. The on-line radioactivity monitor indicated
that the second peak contained two closely eluting phospho-
peptides (2a and 2b) but we were unable to resolve these
preparatively. Although the proportion of radioactivity in
peaks 1^3 was reproducible from digest to digest, the recovery
of radioactivity in peak 4 was variable and on further analy-
sis, it proved to contain a complex mixture of di¡erent la-
belled and unlabelled peptides. We suspect, therefore, that
peak 4 represents incompletely digested material and it was
not analyzed further. HPLC peptide mapping after di¡erent
times of phosphorylation (not shown) revealed that peaks 1,
2a, 2b and 3 appeared at similar rates, although at all time
points, peak 2a contained only about half of the radioactivity
of 1, 2b and 3.
Peaks 1 and 3 were further puri¢ed on Fe3-chelating-Seph-
arose (which selectively binds phosphopeptides and some
other acidic peptides), followed by microbore HPLC and sub-
jected to sequence analysis (Fig. 2B). Pulsed liquid sequencing
of peak 1 gave a single sequence corresponding to residues
278^292 of Mig1p. Solid phase sequencing showed that all of
the [32P]phosphate was released in the ¢rst cycle, correspond-
ing to Ser-278. Pulsed liquid sequencing of peak 3 showed
that it had a single sequence corresponding to residues 308^
322 of Mig1p. Solid phase sequencing showed that all of the
[32P]phosphate was released in the fourth cycle, corresponding
to Ser-311.
Puri¢cation of peaks 2a and 2b was more di⁄cult. They
could not be resolved from each other even after microbore
Fig. 1. Coomassie blue-stained gel (left panel) and autoradiogram
(right panel) of GST (lane 3) and GST-Mig1p (lane 4), phosphoryl-
ated using [Q-32P]ATP and puri¢ed SNF1. Control incubations
lacked GST-Mig1p (lane 1) or SNF1 (lane 2). The polypeptide of
the expected size for GST-Mig1p is indicated by the arrow on the
right, polypeptides of a lower molecular mass are breakdown prod-
ucts. The migration of marker proteins of the indicated molecular
mass is shown.
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HPLC on a C18 column. Pulsed liquid sequencing of this
preparation gave a single major sequence commencing
IPVSVKPPPSL, corresponding to the expected tryptic peptide
from residues 186 to 225 (the bond following Lys-191 would
not be expected to cleave e⁄ciently because it is followed by
proline). However, solid phase sequencing gave a major re-
lease of radioactivity at cycle 3, indicating that the 186^225
peptide was contaminated with another phosphopeptide. We
therefore subdigested with chymotrypsin and puri¢ed the re-
sulting digest on Fe3-chelating-Sepharose, followed by mi-
crobore HPLC. An apparently single radioactive peak was
obtained, which was subjected to pulsed liquid sequencing.
However, two amino acids were obtained in several cycles,
indicating that two peptides were still present (Fig. 2B(C)).
With the aid of the predicted Mig1p sequence, we could assign
the two peptides as SNSHSGSRLK (residues 216^225, de-
rived by chymotryptic digestion from the C-terminal end of
the 186^225 peptide) and STSGTNL (residues 379^385, de-
rived by chymotryptic digestion from the N-terminal end of
the expected tryptic peptide from 379 to 413). On solid phase
sequencing of this peptide, there was a major release of counts
in cycle 3 and a minor peak in cycle 7. Since a release of
radioactivity at cycle 3 was also observed when the tryptic
peptide 186^225 was sequenced, the radioactivity in this cycle
arose from the peptide STSGTNL (379^385) and not from
SNSHSGSRLK (216^225). Taken together, these data are
consistent with Ser-222 and Ser-381 being the two phospho-
rylated sites which generate tryptic peptides 2a/2b, with Ser-
222 being a minor site.
3.3. Site-directed mutagenesis of phosphorylation sites
The phosphorylated serine residues we had identi¢ed within
Mig1p were mutated to non-phosphorylatable acidic residues
(aspartic acid or glutamic acid) by site-directed mutagenesis.
Both wild-type Mig1p and the mutant Mig1p were expressed
in vmig1 yeast and immunoprecipitated using anti-FLAG res-
in. Wild-type Mig1p was readily phosphorylated by SNF1
whereas the S222; 278; 381D/S311E mutant protein was not phos-
phorylated signi¢cantly under these conditions (Fig. 3). Mu-
tation of the phosphorylation sites had no detectable e¡ect on
the level of expression of the proteins, as judged by Western
blotting (data not shown). Similar results were obtained using
GST-Mig1p constructs expressed in bacteria (results not
shown). These results con¢rm that Ser-222, Ser-278, Ser-311
Fig. 2. (A) Reversed phase HPLC separation of tryptic phosphopep-
tides derived from Mig1p, phosphorylated using [Q-32P]ATP and pu-
ri¢ed SNF1. Peptides were separated on a C18 column using the in-
dicated gradient from 0.1% TFA in water to 0.1% TFA in
acetonitrile (dashed line). The continuous line shows the output
from an on-line radioactivity monitor. (B) Amino acid sequencing
of Mig1p phosphopeptides: (A) tryptic peptide 1; (B) tryptic pep-
tide 3; (C) tryptic peptides 2a/2b after subdigestion with chymotryp-
sin and further puri¢cation. Conventional pulsed liquid sequencing
was used to identify the PTH-amino acid(s) release at each cycle
(open circles, note semi-logarithmic plot), whereas parallel solid
phase sequencing runs using peptides covalently attached to Seque-
lon membranes (¢lled circles) were used to investigate the release of
radioactivity. In some cycles in (C), two PTH-amino acids were ob-
served. Note that the recoveries of PTH-serine and -threonine are
always less than expected due to L elimination reactions, especially
if the amino acid was phosphorylated.
Fig. 3. Coomassie blue-stained gel (left panel) and autoradiogram
(right panel) of wild-type (WT) Mig1p (lane 2) and S222; 278; 381D/
S311E (Mut) Mig1p (lane 3). Immune complexes isolated by immu-
noprecipitation from yeast cell lysates expressing either WT-Mig1p
or Mut-Mig1p were incubated in the presence of [Q-32P]ATP and
puri¢ed SNF1. A control incubation containing SNF1 and [Q-32P]-
ATP was included (lane 1). Polypeptides corresponding to the im-
munoglobulin heavy and light chains present in the immune com-
plex are indicated by arrows. The labelled polypeptide correspond-
ing to Mig1p is also indicated by an arrow on the right. The
migration of marker proteins of the indicated molecular mass is
shown.
FEBS 22180 10-6-99
F.C. Smith et al./FEBS Letters 453 (1999) 219^223 221
and Ser-381 are the only sites within Mig1p that are phos-
phorylated to a signi¢cant extent by SNF1 in vitro.
4. Discussion
Our results show that a GST-Mig1p fusion protein is an
excellent substrate for the puri¢ed SNF1 complex. Four sites,
i.e. Ser-222, Ser-278, Ser-311 and Ser-381 were identi¢ed as
being phosphorylated by SNF1. The sequences around Ser-
278, Ser-311 and Ser-381 match the consensus recognition
motif for SNF1 (Table 1), which we have established from
previous synthetic peptide studies [30]. All three sites contain
hydrophobic residues (usually Leu, in one case Phe) at the
P35 and P+4 positions (bold type) and arginine at the P33
position (underlined), where the phosphorylated serine is res-
idue P (bold and increased font size). By contrast, the se-
quence around Ser-222 is not an optimal match to our recog-
nition motif. It has histidine rather than arginine at the P33
position and synthetic peptides with histidine at this position
were phosphorylated 10-fold slower than those with arginine
[30]. It also has asparagine at the P35 position, a residue
which has not yet been tested at this position in our peptide
studies. Although not hydrophobic, asparagine is a reason-
ably bulky uncharged side chain and it is possible that it
can be accommodated in the putative pocket on SNF1 [30]
which binds the P35 hydrophobic side chain.
Recently, Cassart et al. [31] have cloned a Mig1p homo-
logue from the distantly related yeast Kluyveromyces lactis
(KlMig1) and have shown that it restores glucose-repressible
SUC2 expression when expressed in a mig1 mutant of S. ce-
revisiae. Since the Mig1p function is therefore conserved be-
tween S. cerevisiae and K. lactis, it was of interest to see
whether the phosphorylation sites identi¢ed in the S. cerevi-
siae protein (ScMig1) are conserved in K. lactis. Table 1 shows
that the Ser-278 and Ser-311 sites from ScMig1 are conserved
in KlMig1 (Ser-305 and Ser-329, respectively) and that the
residues at P35, P33 and P+4 critical for recognition are
also conserved, except that Ser-329 on KlMig1 has asparagine
at the P35 position. As noted above, S. cerevisiae SNF1 does
phosphorylate at least one site with asparagine at the P35
position (Ser-222 on ScMig1). The Ser-222 and Ser-381 sites
are not conserved in KlMig1 (Table 1). A serine is present at
position 397 (which aligns with Ser-381 in ScMig1) in KlMig1,
but the critical residues at P35, P33 and P+4 are not con-
served.
Based on the conservation with K. lactis, we would there-
fore argue that Ser-278 and Ser-311 on ScMig1 are the key
sites, with Ser-222 and Ser-381 being secondary sites which
may not have a critical function. Ronne’s group [27] has re-
cently de¢ned a domain in ScMig1 (the R1 domain, residues
241^351) which is critical for SNF1-dependent gene regula-
tion. This corresponds closely to the region (residues 261^
400) required for SNF1-dependent nuclear to cytoplasmic
translocation of Mig1p [26]. Intriguingly, Ser-278 and Ser-
311 are both within the R1 domain, while Ser-222 and Ser-
381 lie just outside it, on the N- and C-terminal sides, respec-
tively. Using a Mig1-VP16 fusion in which the C-terminal
e¡ector domain of Mig1p was replaced by the activator do-
main of viral protein 16 (VP16), Ronne’s group [27] created a
factor which activated transcription from reporter genes con-
taining Mig1p promoter elements. This activation was inhib-
ited 5-fold in a SNF1 strain compared to a vsnf1 strain, but
only under derepressing conditions when the SNF1 complex
would be active [7,20]. Deletion of the R1 domain completely
abolished control by SNF1 and led to constitutive expression.
Based on our previously published recognition motif for the
SNF1 complex [30], Ronne’s group independently identi¢ed
Ser-278 and Ser-311 as potential SNF1 sites within the R1
domain and recently, they reported that mutation of both of
these sites (together with Ser-310) to alanine in the Mig1-
VP16 fusion resulted in an almost complete abolition of the
e¡ect of SNF1 (from 6.1-fold to 1.6-fold) [32]. Mutation of
Ser-278 or Ser-310/Ser-311 alone reduced the e¡ect of SNF1
to 2.0-fold and 2.6-fold, respectively. Our results now con¢rm
that the SNF1 complex does indeed phosphorylate Ser-278
and Ser-311 e⁄ciently in vitro. Using a mobility shift assay,
Ronne’s group also reported that the Mig1-Vp16 protein was
phosphorylated on multiple sites and that mutation of Ser-278
and Ser-310/Ser-311 reduced, but did not abolish, the SNF1-
dependent phosphorylation [32]. In an independent study,
Carlson’s group also used the recognition motif for SNF1 in
order to identify potential phosphorylation sites. Mutation of
Ser-222, Ser-278, Ser-311 and Ser-381 (together with Ser-310,
Ser-379 and Thr-380) to alanine reduced most of the phos-
phorylation of a LexA-Mig1p fusion in response to low glu-
cose, although not as substantially as did mutation of SNF1
[33]. These results suggest that Mig1p contains additional sites
for SNF1-dependent phosphorylation. Our data show that
SNF1 phosphorylates Ser-222, Ser-278, Ser-311 and Ser-381
in vitro, but not at any other sites to any signi¢cant extent. It
remains possible that Mig1p is phosphorylated at additional
sites by a SNF1-dependent protein kinase. Consistent with
this is the ¢nding by Ronne’s group that Mig1-Vp16 may
Table 1
The alignments of phosphorylated sites on S. cerevisiae Mig1p
(ScMig1) with the homologous sites on K. lactis Mig1p (KlMig1)
are shown
The S. cerevisiae and K. lactis sequences were aligned by the GAP
program, using default settings, within GCG. The phosphorylated
serines in S. cerevisiae and the aligned residues in K. lactis are in an
increased font size and bold type. The recognition motif for the
SNF1 kinase [29] is shown in italics and residues thought to be im-
portant for phosphorylation are highlighted (in bold (P35 and P+4)
or underlined (P33)). Residues in KlMig1 that do not match the
recognition motif are boxed. Hyd represents a hydrophobic amino
acid and Xaa any amino acid.
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be phosphorylated at Ser-108, which, our results clearly show,
is not phosphorylated by SNF1 in vitro.
Taken this together with the ¢ndings of Ronne’s and Carl-
son’s groups [27,32,33] and our own previous results showing
that the SNF1 complex is activated by glucose removal [7,20],
our current results strongly suggest that derepression of glu-
cose-repressed genes is brought about in part by direct phos-
phorylation of Mig1p by SNF1.
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